Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 12 October 1984:
Vol. 226. no. 4671, pp. 180 - 182
DOI: 10.1126/science.6484569
Prev | Table of Contents | Next

Articles

Science, Vol 226, Issue 4671, 180-182
Copyright © 1984 by American Association for the Advancement of Science

articles

Retarding effect of lowered heart rate on coronary atherosclerosis

PA Beere, S Glagov, and CK Zarins

The role of heart rate in the development of coronary atherosclerosis was assessed in adult male cynomolgus monkeys (Macaca fascicularis). Heart rate was lowered in six animals by surgical ablation of the sinoatrial node. A sham procedure, which included all of the surgical steps except for sinoatrial node ablation, was carried out in eight animals. All of the monkeys were fed an atherogenic high cholesterol diet for 6 months, and heart rates were monitored repeatedly by telemetry during 24-hour test periods. Coronary atherosclerosis in animals with postoperative heart rates less than the preoperative mean for all of the animals that underwent surgery was less than half that of animals with heart rates above the mean or of diet-fed control animals not subjected to surgery. Groups did not differ in blood pressure, serum lipids, or body weight. These results suggest that heart rate in itself may contribute to the mechanisms by which behavioral patterns and physical training influence coronary artery disease.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Vascular endothelial ageing, heartbeat after heartbeat.
E. Thorin and N. Thorin-Trescases (2009)
Cardiovasc Res 84, 24-32
   Abstract »    Full Text »    PDF »
Heart rate and atherosclerosis.
J.-C. Tardif (2009)
Eur. Heart J. Suppl. 11, D8-D12
   Abstract »    Full Text »    PDF »
Improvement of Endothelial Function of the Corpus Cavernosum in Apolipoprotein E Knockout Mice Treated with Irbesartan.
M. Baumhakel, F. Custodis, N. Schlimmer, U. Laufs, and M. Bohm (2008)
J. Pharmacol. Exp. Ther. 327, 692-698
   Abstract »    Full Text »    PDF »
Nighttime Heart Rate and Survival in Depressed Patients Post Acute Myocardial Infarction.
R. M. Carney, B. Steinmeyer, K. E. Freedland, J. A. Blumenthal, P. K. Stein, W. A. Steinhoff, W. B. Howells, L. F. Berkman, L. L. Watkins, S. M. Czajkowski, et al. (2008)
Psychosom Med 70, 757-763
   Abstract »    Full Text »    PDF »
The pivotal role of heart rate in clinical practice: from atherosclerosis to acute coronary syndrome.
J.-C. Tardif (2008)
Eur. Heart J. Suppl. 10, F11-F16
   Abstract »    Full Text »    PDF »
Heart rate management: a therapeutic goal throughout the cardiovascular continuum.
J. L. Zamorano (2008)
Eur. Heart J. Suppl. 10, F17-F21
   Abstract »    Full Text »    PDF »
Nebivolol, but Not Metoprolol, Improves Endothelial Function of the Corpus Cavernosum in Apolipoprotein E-Knockout Mice.
M. Baumhakel, N. Schlimmer, K. Buyukafsar, O. Arikan, and M. Bohm (2008)
J. Pharmacol. Exp. Ther. 325, 818-823
   Abstract »    Full Text »    PDF »
Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E-Deficient Mice.
F. Custodis, M. Baumhakel, N. Schlimmer, F. List, C. Gensch, M. Bohm, and U. Laufs (2008)
Circulation 117, 2377-2387
   Abstract »    Full Text »    PDF »
Is there benefit of cardiac slowing drugs in the treatment of hypertensive patients with elevated heart rate?.
P. Palatini (2008)
Eur. Heart J. 29, 1218-1220
   Full Text »    PDF »
The heart rate hypothesis: ready to be tested.
A S Hall and S Palmer (2008)
Heart 94, 561-565
   Abstract »    Full Text »    PDF »
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).
Authors/Task Force Members, I. Graham, D. Atar, K. Borch-Johnsen, G. Boysen, G. Burell, R. Cifkova, J. Dallongeville, G. De Backer, S. Ebrahim, et al. (2007)
Eur. Heart J. 28, 2375-2414
   Full Text »    PDF »
Heart rate: an independent risk factor in cardiovascular disease.
A. Hjalmarson (2007)
Eur. Heart J. Suppl. 9, F3-F7
   Abstract »    Full Text »    PDF »
High heart rate: a cardiovascular risk factor?.
S. Cook, M. Togni, M. C. Schaub, P. Wenaweser, and O. M. Hess (2006)
Eur. Heart J. 27, 2387-2393
   Full Text »    PDF »
From coronary artery disease to heart failure: potential benefits of ivabradine.
J.-C. Tardif and C. Berry (2006)
Eur. Heart J. Suppl. 8, D24-D29
   Abstract »    Full Text »    PDF »
Heart rate reduction through lifestyle modification: reply.
J.-C. Tardif, A. Diaz, and M. G. Bourassa (2005)
Eur. Heart J. 26, 1807
   Full Text »    PDF »
Editorial: If inhibition: from pure heart reduction to treatment of stable angina.
M. Tendera (2005)
Eur. Heart J. Suppl. 7, H3-H6
   Full Text »    PDF »
Future perspectives of If inhibition in various cardiac conditions.
K. Fox (2005)
Eur. Heart J. Suppl. 7, H33-H36
   Abstract »    Full Text »    PDF »
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.
A. Diaz, M. G. Bourassa, M.-C. Guertin, and J.-C. Tardif (2005)
Eur. Heart J. 26, 967-974
   Abstract »    Full Text »    PDF »
Depression, the Autonomic Nervous System, and Coronary Heart Disease.
R. M. Carney, K. E. Freedland, and R. C. Veith (2005)
Psychosom Med 67, S29-S33
   Abstract »    Full Text »    PDF »
Strain-Dependent Vascular Remodeling: The "Glagov Phenomenon" Is Genetically Determined.
V. A. Korshunov and B. C. Berk (2004)
Circulation 110, 220-226
   Abstract »    Full Text »    PDF »
Increased heart rate as a risk factor for cardiovascular disease.
B.N. Singh (2003)
Eur. Heart J. Suppl. 5, G3-G9
   Abstract »    PDF »
Prognostic benefits of heart rate reduction in cardiovascular disease.
R. Ferrari, S. Censi, F. Mastrorilli, and A. Boraso (2003)
Eur. Heart J. Suppl. 5, G10-G14
   Abstract »    PDF »
Chronic heart rate reduction with ivabradine and prevention of atherosclerosis progression assessed using intravascular ultrasound.
J.-C. Tardif, J. Gregoire, P.L. Lallier, and M. Joyal (2003)
Eur. Heart J. Suppl. 5, G46-G51
   Abstract »    PDF »
If current inhibition with ivabradine: further perspectives.
N. Danchin (2003)
Eur. Heart J. Suppl. 5, G52-G56
   Abstract »    PDF »
Effects of Heart Rate Changes on Arterial Distensibility in Humans.
C. Giannattasio, A. Vincenti, M. Failla, A. Capra, A. Ciro, S. De Ceglia, G. Gentile, R. Brambilla, and G. Mancia (2003)
Hypertension 42, 253-256
   Abstract »    Full Text »    PDF »
Predictive Value of Clinic and Ambulatory Heart Rate for Mortality in Elderly Subjects With Systolic Hypertension.
P. Palatini, L. Thijs, J. A. Staessen, R. H. Fagard, C. J. Bulpitt, D. L. Clement, P. W. de Leeuw, M. Jaaskivi, G. Leonetti, C. Nachev, et al. (2002)
Arch Intern Med 162, 2313-2321
   Abstract »    Full Text »    PDF »
Diabetes, Heart Rate, and Mortality.
N. Singh (2002)
Journal of Cardiovascular Pharmacology and Therapeutics 7, 117-129
   Abstract »    PDF »
Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate.
B. N. Singh (2001)
Journal of Cardiovascular Pharmacology and Therapeutics 6, 313-331
   PDF »
Is the pulse rate useful in assessing risk of diabetic retinopathy and macular oedema? The Wisconsin Epidemiological Study of Diabetic Retinopathy.
T. Y. Wong, S. E Moss, R. Klein, and B. E K Klein (2001)
Br J Ophthalmol 85, 925-927
   Abstract »    Full Text »    PDF »
Cardiorespiratory Fitness and the Progression of Carotid Atherosclerosis in Middle-Aged Men.
T. A. Lakka, J. A. Laukkanen, R. Rauramaa, R. Salonen, H.-M. Lakka, G. A. Kaplan, and J. T. Salonen (2001)
Ann Intern Med 134, 12-20
   Abstract »    Full Text »    PDF »
Measurement of heart rate variability: a clinical tool or a research toy?.
H. V. Huikuri, T. Makikallio, K. E. J. Airaksinen, R. Mitrani, A. Castellanos, and R. J. Myerburg (1999)
J. Am. Coll. Cardiol. 34, 1878-1883
   Abstract »    Full Text »    PDF »
Heart Rate Variability and Progression of Coronary Atherosclerosis.
H. V. Huikuri, V. Jokinen, M. Syvanne, M. S. Nieminen, K. E. J. Airaksinen, M. J. Ikaheimo, J. M. Koistinen, H. Kauma, A. Y. Kesaniemi, S. Majahalme, et al. (1999)
Arterioscler Thromb Vasc Biol 19, 1979-1985
   Abstract »    Full Text »    PDF »
Potential interests of heart rate lowering drugs.
T Laperche, D Logeart, A Cohen-Solal, and R Gourgon (1999)
Heart 81, 336-341
   Full Text »
Relationship of Tachycardia With High Blood Pressure and Metabolic Abnormalities : A Study With Mixture Analysis in Three Populations.
P. Palatini, E. Casiglia, P. Pauletto, J. Staessen, N. Kaciroti, and S. Julius (1997)
Hypertension 30, 1267-1273
   Abstract »    Full Text »
Behaviorally Elicited Heart Rate Reactivity and Atherosclerosis in Ovariectomized Cynomolgus Monkeys (Macaca fascicularis).
S. B. Manuck, M. R. Adams, J. M. McCaffery, and J. R. Kaplan (1997)
Arterioscler Thromb Vasc Biol 17, 1774-1779
   Abstract »    Full Text »
Poland and United States Collaborative Study on Cardiovascular Epidemiology : A Comparison of HDL Cholesterol and Its Subfractions in PopulationsCovered by the United States Atherosclerosis Risk in Communities Study and thePol-MONICA Project.
G. Broda, C. E. Davis, A. Pajak, O. D. Williams, S. L. Rywik, E. Baczynska, A. R. Folsom, and M. Szklo (1996)
Arterioscler Thromb Vasc Biol 16, 339-349
   Abstract »    Full Text »
Pressure-Induced Arterial Wall Stress and Atherosclerosis.
M. J. Thubrikar and F. Robicsek (1995)
Ann. Thorac. Surg. 59, 1594-1603
   Abstract »    Full Text »
Physical Fitness as a Predictor of Mortality among Healthy, Middle-Aged Norwegian Men.
L. Sandvik, J. Erikssen, E. Thaulow, G. Erikssen, R. Mundal, and K. Rodahl (1993)
N. Engl. J. Med. 328, 533-537
   Abstract »    Full Text »
{beta}-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure.
B. M. Psaty, T. D. Koepsell, J. P. LoGerfo, E. H. Wagner, and T. S. Inui (1989)
JAMA 261, 2087-2094
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)